Chimera Investment (CIM) Stock Price, News & Analysis

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Chimera Investment in the last twelve months. There are currently 2 hold ratings and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "hold" CIM shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CIM, but not buy additional shares or sell existing shares.
View CIM analyst ratings or view top-rated stocks.

3 brokers have issued 1-year target prices for Chimera Investment's shares. Their CIM share price targets range from $5.50 to $7.00. On average, they predict the company's share price to reach $6.00 in the next twelve months. This suggests a possible upside of 20.2% from the stock's current price.
View analysts price targets for CIM or view top-rated stocks among Wall Street analysts.

Chimera Investment's stock was trading at $5.50 at the start of the year. Since then, CIM shares have decreased by 9.3% and is now trading at $4.99.
View the best growth stocks for 2023 here.

Chimera Investment saw a decline in short interest during the month of December. As of December 15th, there was short interest totaling 5,540,000 shares, a decline of 11.6% from the November 30th total of 6,270,000 shares. Based on an average daily trading volume, of 2,320,000 shares, the short-interest ratio is presently 2.4 days. Currently, 2.5% of the shares of the company are sold short.
View Chimera Investment's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Wednesday, February 21st 2024.
View our CIM earnings forecast.

Chimera Investment Co. (NYSE:CIM) issued its earnings results on Thursday, May, 4th. The real estate investment trust reported $0.13 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.16 by $0.03. The real estate investment trust had revenue of $189.25 million for the quarter, compared to analysts' expectations of $86.60 million. Chimera Investment had a net margin of 25.07% and a trailing twelve-month return on equity of 7.26%. During the same period in the prior year, the business earned $0.39 EPS.

Chimera Investment announced a quarterly dividend on Thursday, November 2nd. Investors of record on Friday, December 29th will be given a dividend of $0.11 per share on Wednesday, January 31st. This represents a $0.44 annualized dividend and a dividend yield of 8.82%. The ex-dividend date of this dividend is Thursday, December 28th.
Read our dividend analysis for CIM.

Chimera Investment (NYSE:CIM) pays an annual dividend of $0.44 per share and currently has a dividend yield of 8.82%. CIM has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The dividend payout ratio is 84.62%. Payout ratios above 75% are not desirable because they may not be sustainable. Based on EPS estimates, CIM will have a dividend payout ratio of 84.62% in the coming year. This indicates that the company may not be able to sustain their current dividend.
Read our dividend analysis for CIM.

ETFs with the largest weight of Chimera Investment (NYSE:CIM) stock in their portfolio include Invesco KBW High Dividend Yield Financial ETF (KBWD), VanEck Mortgage REIT Income ETF (MORT), iShares Mortgage Real Estate ETF (REM), WisdomTree Alternative Income Fund (HYIN) and Hoya Capital High Dividend Yield ETF (RIET).Global X SuperDividend ETF (SDIV).

Chimera Investment announced that its Board of Directors has authorized a share repurchase plan on Wednesday, June 14th 2023, which authorizes the company to buyback $250,000,000.00 in outstanding shares, according to EventVestor. This buyback authorization authorizes the company to purchase up to 19% of its stock through open market purchases. Stock buyback plans are generally a sign that the company's leadership believes its stock is undervalued.

3 employees have rated Chimera Investment Chief Executive Officer Matthew Lambiase on Glassdoor.com. Matthew Lambiase has an approval rating of 100% among the company's employees. This puts Matthew Lambiase in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

Based on aggregate information from My MarketBeat watchlists, some companies that other Chimera Investment investors own include New Residential Investment (NRZ), Annaly Capital Management (NLY), Marathon Oil (MRO), AGNC Investment (AGNC), Energy Transfer (ET), AT&T (T), ARMOUR Residential REIT (ARR), New York Mortgage Trust (NYMT), Enterprise Products Partners (EPD) and NGL Energy Partners (NGL).

Shares of CIM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.